A conversation with Dr. Dennis Slamon, director of the Revlon/UCLA Cancer Center, Dr. Larry Norton of New York's Memorial Sloan Kettering Cancer, Dr. Lynn Schuchter, oncologist at the University of Pennsylvania and Carol Hochberg of the Ethics Committee at S.H.A.R.E., about breakthroughs in cancer treatment and new drugs which have yet to be approved.